Icahn's Icahn Capital Shows New 6.3M Share Stake in Amylin Pharma (AMLN)
Tweet
Share
E-mailGet Alerts AMLN Hot Sheet
Join SI Premium – FREE
Carl Icahn's Icahn Capital latest 13F shows he built a stake in Amylin Pharmaceuticals Inc. (Nasdaq: AMLN).
Icahn showed a new 6,339,653 share stake in AMLN.
Amylin Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of medicines for diabetes, obesity, and other diseases in the United States.
Icahn showed a new 6,339,653 share stake in AMLN.
Amylin Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of medicines for diabetes, obesity, and other diseases in the United States.
You May Also Be Interested In
- Mavis acquires Pep Boys from Icahn Enterprises for $700M
- Beeline CEO puts $500,000 into company via convertible note
- Intel CEO to buy $12 million in company stock in recent stock offering
Create E-mail Alert Related Categories
Insider Trades, Insiders' BlogRelated Entities
Carl IcahnSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
